
ACS Infectious Diseases, Год журнала: 2024, Номер 10(12), С. 4087 - 4102
Опубликована: Ноя. 20, 2024
Antimicrobial resistance (AMR) poses a serious threat to global health. The rapid emergence of contrasts with the slow pace antimicrobial development, emphasizing urgent need for innovative drug discovery approaches. This study addresses critical bottleneck in early development by introducing integral solvent-induced protein precipitation (iSPP) rapidly assess target–engagement lead compounds extracts pathogenic microorganisms under close-to-physiological conditions. iSPP measures change stability against presence ligands. method bacteria builds upon established SPP procedures and features optimized denaturation gradients minimized sample input amounts. effectiveness workflow was initially demonstrated through multidrug study. Using quantitative mass spectrometry (LC-MS/MS), we successfully identified known targets seven different antibiotics cell four AMR-related pathogens: three Gram-negative Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa Gram-positive bacterium Staphylococcus aureus. ultimately applied demonstrate derived from target-based discovery. We employed five small molecules targeting enzymes 2-C-methyl-d-erythritol 4-phosphate (MEP) pathway─a promising focus anti-infective development. showcases adaptability efficiency identifying targets, advancing early-stage AMR.
Язык: Английский